Trial Profile
Effect of temozolomide in response rate in patients with metastatic colorectal cancer tumour MGMT promoter methylation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Dec 2015 New trial record